KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Non-Current Deffered Revenue (2016 - 2020)

Rigel Pharmaceuticals (RIGL) has 11 years of Non-Current Deffered Revenue data on record, last reported at $146000.0 in Q3 2020.

  • For Q3 2020, Non-Current Deffered Revenue fell 99.42% year-over-year to $146000.0; the TTM value through Sep 2020 reached $146000.0, down 99.42%, while the annual FY2019 figure was $1.4 million, 1460.0% up from the prior year.
  • Non-Current Deffered Revenue reached $146000.0 in Q3 2020 per RIGL's latest filing, down from $1.6 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $26.4 million in Q2 2019 and bottomed at $90000.0 in Q4 2017.
  • Average Non-Current Deffered Revenue over 5 years is $6.2 million, with a median of $1.2 million recorded in 2016.
  • Peak YoY movement for Non-Current Deffered Revenue: soared 14720.79% in 2019, then plummeted 99.42% in 2020.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $279000.0 in 2016, then crashed by 67.74% to $90000.0 in 2017, then changed by 0.0% to $90000.0 in 2018, then skyrocketed by 1460.0% to $1.4 million in 2019, then plummeted by 89.6% to $146000.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Non-Current Deffered Revenue were $146000.0 in Q3 2020, $1.6 million in Q1 2020, and $1.4 million in Q4 2019.